Expert Review of Hematology

Title Publication Date Language Citations
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches2016/11/16English37
Perspectives on the impact of JAK-inhibitor therapy upon inflammation-mediated comorbidities in myelofibrosis and related neoplasms2014/02/13English37
Management of joint bleeding in hemophilia2012/08/01English37
The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait2017/10/30English36
Recent treatment guidelines for managing adult patients with sickle cell disease: challenges in access to care, social issues, and adherence2016/05/24English35
Clinical management of the hypereosinophilic syndromes2012/06/01English35
Iron chelation therapy in myelodysplastic syndromes: where do we stand?2013/08/01English35
Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes2009/02/01English35
Nelarabine in the treatment of pediatric and adult patients with T-cell acute lymphoblastic leukemia and lymphoma2016/12/08English35
Diagnosis and management offactor V Leiden2016/10/31English35
Real-world treatment patterns and associated progression-free survival in relapsed/refractory multiple myeloma among US community oncology practices2016/06/16English34
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures2020/04/29English34
Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation2012/06/01English33
Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia2020/01/11English33
Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd2020/03/09English33
Immunomodulatory drugs in multiple myeloma2013/02/01English33
Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update2019/07/16English33
Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia2019/11/19English33
The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?2011/10/01English32
Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia2010/08/01English32
Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells2010/08/01English32
The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery2013/12/01English32
Diabetes and Glucose Metabolism in Thalassemia Major: An Update2016/02/12English32
Monitoring plasma levels of factor Xa inhibitors: how, why and when?2013/04/01English32
Environmental-mediated drug resistance: a target for multiple myeloma therapy2009/12/01English31
Pathogenesis and management of myeloma bone disease2009/08/01English31
Diagnostic criteria and laboratory tests for disseminated intravascular coagulation2012/12/01English31
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?2017/05/04English31
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment2012/10/01English31
Quality of life in multiple myeloma: considerations and recommendations2019/05/15English31